Mumbai's Medical Community Calls for Accountability and Quality in Drug Prescriptions

▴
Mumbai's medical community is advocating for accountability and transparency in the pharmaceutical industry while expressing reservations about the exclusive prescription of generic drugs. The concerns raised underline the need for a balanced approach that ensures patient safety, affordability, and quality in healthcare.

The medical community in Mumbai is expressing concerns about the quality of drugs produced in substandard manufacturing facilities. They are highlighting the importance of holding manufacturers accountable for the quality of medications and emphasizing the need for strict enforcement of patient safety and care.

 

These concerns have arisen in response to regulations issued by the National Medical Commission (NMC) that recommend doctors exclusively prescribe generic medicines. This directive is intended to prevent potential consequences associated with specific brand-name drugs.

 

A representative from a pharmaceutical company revealed that medicines undergo rigorous quality and safety assessments at multiple stages before they receive approval and patents. According to the United States Food and Drug Administration (USFDA), generic drugs are designed to be identical to brand-name drugs in terms of dosage form, safety, strength, route of administration, quality, performance characteristics, and intended use.

 

Anil Navandar, the Secretary of the Maharashtra State Chemists and Druggists Association, pointed out that India plays a significant role in global medicine exports (13-14%) and cautioned that the government should have carefully considered the impact of such regulations on the pharmaceutical industry. He expressed concerns that these rules might inadvertently allow certain pharmaceutical companies to manufacture substandard medicines without proper quality checks and controls.

 

Navandar further explained that prescribing generic drugs could present practical challenges for doctors, as different factors need consideration based on the specific disease. He also noted that for transparency, equal pricing should be established for all medicines to ensure affordability for all patients. He expressed skepticism about the efficacy of the government's approach and suggested it might lead to the misuse of antibiotics.

 

In response to these concerns, a meeting involving various chemist associations is scheduled for August 19 to discuss the implications of the NMC regulations. Senior officials acknowledged that medical stores often avoid stocking generic medicines due to low profit margins. Additionally, when generics are unavailable, pharmacists may opt for higher-profit-margin brands, regardless of their quality. They also highlighted that not all generic medicines are of the same quality.

 

Senior officials from chemist associations recommended that the guidelines clarify whether prescribing generics is mandatory or merely suggested. They proposed that instead of focusing on urging doctors to prescribe generics, the government should prioritize promoting the manufacturing of generic medicines.

 

 Mumbai's medical community is advocating for accountability and transparency in the pharmaceutical industry while expressing reservations about the exclusive prescription of generic drugs. The concerns raised underline the need for a balanced approach that ensures patient safety, affordability, and quality in healthcare.

Tags : #NMC #Mumbaidoctors #Genericdrugs #patientsafety #healthcare #awareness #India

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026